malignant tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age from 2-18 years old without gender limitation; 2. Diagnosed as NHL and receiving intensified treatment; diagnosed as high-risk neuroblastoma; 3. Experienced bone marrow suppression of III-IV degrees during last chemotherapy; 4. The legal guardians agree to receive the Chinese Medicine and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Critical condition and unable to eat due to illness; 2. Severe and lasting adverse reactions of gastrointestinal tract after chemotherapy, and can not take Chinese medicine; 3. Allergic to the components of traditional Chinese medicine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peripheral blood routine;blood and bone marrow (CTCAE v3.0); | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score;PedsQL3.0; | — |
Countries
China
Contacts
Xinhua Hospital Affliated to Shanghai Jiaotong University School of Medicine